DEUTSCHE BANK AG\ - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2022$26,000
-64.9%
11,343
-10.6%
0.00%
Q4 2021$74,000
-41.3%
12,683
+5.5%
0.00%
Q3 2021$126,000
+180.0%
12,021
+158.3%
0.00%
Q2 2021$45,000
-82.3%
4,653
-73.3%
0.00%
Q1 2021$254,00017,4320.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Alpha Wave Global, LP 213,658$3,104,0000.19%
Serengeti Asset Management LP 20,000$291,0000.13%
FORMULA GROWTH LTD 56,276$818,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 375,000$5,449,0000.12%
TUDOR INVESTMENT CORP ET AL 113,353$1,647,0000.03%
Duquesne Family Office 100,000$1,453,0000.03%
PURA VIDA INVESTMENTS, LLC 67,357$941,0000.03%
MOORE CAPITAL MANAGEMENT, LP 127,500$1,853,0000.02%
Zimmer Partners, LP 46,000$668,0000.01%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 26,000$376,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders